Longer‐acting clotting factor concentrates for hemophilia

E-ISSN： 1538-7836|13|S1|S167-S175

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.13, Iss.S1, 2015-06, pp. : S167-S175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Switching from current factor VIII (FVIII) to longer acting FVIII concentrates – what is the real potential benefit?

HAEMOPHILIA, Vol. 21, Iss. 3, 2015-05 ,pp. : 297-299

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factor VIII Inhibitors in Patients with Hemophilia A

Acta Haematologica, Vol. 102, Iss. 1, 1999-09 ,pp. : 42-46

Karger

Access to resources Recommend Favorite

Elevated Clotting Factor Levels and Venous Thrombosis

Pathophysiology of Haemostasis and Thrombosis, Vol. 33, Iss. 5-6, 2005-01 ,pp. : 395-400

Karger

Access to resources Recommend Favorite

6 Factor VIII Concentrates, Factor VIII/von Willebrand Factor Concentrates, Factor IX Concentrates, Activated Prothrombin Complex Concentrates

Transfusion Medicine and Hemotherapy, Vol. 36, Iss. 6, 2009-12 ,pp. : 409-418

Karger

Access to resources Recommend Favorite

Half‐life extended factor VIII for the treatment of hemophilia A

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. S1, 2015-06 ,pp. : S176-S179

John Wiley & Sons Inc

Access to resources Recommend Favorite